Global Fluoropolymer in Healthcare Market Research Report 2022

Fluoropolymers are fluorocarbon based polymers formed by strong bonds between carbon and fluorine, which makes them mechanically stable. They are high-performance plastics with high acid, alkali and solvent resistance. Various fluoropolymer products, such as polytetrafluoroethylene (PTFE), polyvinylidene fluoride (PVDF), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), polytrifluoroethylene (PCTFE), polyfluoroethylene (PVF), ethylene trifluoroethylene (ECTFE), perfluoroalkoxy (PFA), and fluoroelastomers are usually used in the medical market.
Due to the COVID-19 pandemic, the global Fluoropolymer in Healthcare market size is estimated to be worth US$ 714.7 million in 2021 and is forecast to a readjusted size of US$ 949.8 million by 2028 with a CAGR of 4.5% during the review period. Fully considering the economic change by this health crisis, the Europe Fluoropolymer in Healthcare market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Fluoropolymer in Healthcare landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Global key fluoropolymer in healthcare 核心厂商 Chemours, Daikin, Solvay etc. The top 4 companies hold a share about 46%. North America is the largest market, with a share about 38%, followed by Asia-Pacific and Europe both with the share about 28%. In terms of product, PTFE is the largest segment, with a share over 59%. And in terms of application, the largest application is medical disposables, followed by medical devices and pharmaceutical packaging.
This report focuses on Fluoropolymer in Healthcare volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Fluoropolymer in Healthcare market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and India, etc.
Global Fluoropolymer in Healthcare Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
PTFE
PVDF
FEP
PFA
Others
Segment by Application
Medical Disposables
Pharmaceutical Packaging
Medical Devices
Drug Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Chemours
Daikin
Solvay
3M
AGC
Saint-Gobain
W.L.Gore & Associates
Arkema
Gujarat
HaloPolymer
Zeus
Donaldson